데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
143879-77-0N#Cc1c(F)ccc([N+](=O)[O-])c1FJQHDRFKDZHGEBQ-UHFFFAOYSA-N143879-77-0DTXSID80371785Light yellow crystalline
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Danger
H301+H311+H331 (33.3%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
용도2,6-Difluoro-3-nitrobenzonitrile is an aliphatic compound that inhibits the activity of monoamines by binding to the endogenously produced 2,6-difluoro-3-nitrobenzonitrile (DNFB). DNFB is a nitrosamine that has been shown to be a potent inhibitor of muscle contraction. This inhibition occurs at high concentrations and has been found in muscle cells. It has also been shown to inhibit the production of nitric oxide from monoxide or homologous nitrates, which may lead to atherosclerosis. 2,6-Difluoro-3-nitrobenzonitrile is also an amine and exhibits structural similarities with other members of this family.